|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL.: (2006.01) |
A61K 31/40 A61K 31/41 C07D 207/00 C07D 231/00 C07D 233/00 C07D 249/00 C07D 257/00 C07D 401/00 C07D 403/00 C07D 409/00 C07D 413/00 |
| (11) | Number of the document | 4673 |
| (13) | Kind of document | B |
| (21) | Application number | 99-076 |
| (22) | Date of filing the application | 1999-06-22 |
| (41) | Date of publication of the application | 2000-02-25 |
| (45) | Date of publication of patent | 2000-07-25 |
| (86) | Number | PCT/US97/22895 |
| Date | 1997-12-15 |
| (87) | Number | WO 98/28269 |
| Date | 1998-07-02 |
| (30) | Number | Date | Country code |
| 769859 | 1996-12-23 | US | |
| 879944 | 1997-06-20 | US |
| (71) |
DUPONT PHARMACEUTICALS COMPANY,
Chestnut Run Plaza, 974 Centre Road, Wilmington, Delaware,
US
|
| (72) |
Donald Joseph Phillip PINTO, US
James Russell PRUITT, US Joseph CACCIOLA, US John Matthew FEVIG, US Qi HAN, US Michael James ORWAT, US Mimi Lifen QUAN, US Karen Anita ROSSI, US |
| (73) |
BRISTOL-MYERS SQUIBB PHARMA COMPANY,
Route 206 & Provinceline Road, Princeton, New Jersey 08543-4000,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2003-11-10 | 7 | 560.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2004-12-15 |